SPDR S&P Biotech ETF (NYSEARCA:XBI) Holdings Trimmed by LGL Partners LLC

LGL Partners LLC lowered its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 0.6% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 22,813 shares of the exchange traded fund’s stock after selling 138 shares during the quarter. LGL […]

Related Keywords

United States ,American , ,National Association Of Securities Dealers Automated Quotation ,York Stock Exchange ,Wetzel Investment Advisors Inc ,Life Planning Partners Inc ,Nasdaq ,National Market ,Wealth Management ,Securities Exchange Commission ,American Stock Exchange ,New York Stock Exchange ,Lgl Partners ,Free Report ,Valley Asset Management Partners ,Investment Advisors ,Smith Wealth Management ,National Association ,Securities Dealers Automated Quotation ,Visit Holdingschannel ,Spdr Sp Biotech Etf ,Nysearca Xbi ,Xbi ,Nysearca ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,